{"id":"W2173572264","doi":"10.1093/annonc/mdv324","title":"A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma","year":2015,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre","funders":"National Cancer Institute; Celgene","keywords":"Dacarbazine; Medicine; Paclitaxel; Internal medicine; Clinical endpoint; Hazard ratio; Chemotherapy; Melanoma; Neutropenia; Oncology; Randomized controlled trial; Gastroenterology; Progression-free survival; Confidence interval; Urology; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001667624,0.001383628,0.00282295,0.0004127367,0.0004992269,0.001068981,0.001014158,0.001379465,0.005640978],"category_scores_gemma":[0.002460488,0.0006684713,0.001486907,0.0004906691,0.001302971,0.001100368,0.0003895025,0.003892522,0.0009068867],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009708427,"about_ca_system_score_gemma":0.001440163,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001700313,"about_ca_topic_score_gemma":0.004435085,"domain_scores_codex":[0.999308,0.0004051565,0.00003708142,0.0001142413,0.00004092789,0.00009457765],"domain_scores_gemma":[0.998813,0.0004027923,0.000215504,0.0001023398,0.00007116992,0.0003951062],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9809686,0.005587948,0.0005081329,0.0003085046,0.0006190319,0.0000235892,0.00003937708,0.0003095109,0.001293539,0.00007746967,0.0005154112,0.009748807],"study_design_scores_gemma":[0.970409,0.02811446,0.0006305727,0.00001335899,0.0001880745,0.0000154783,0.00001415712,0.000193668,0.00009831154,0.00007902025,0.000238471,0.000005444841],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872451,0.004069183,0.0006048959,0.001002145,0.0008822477,0.003376836,0.000633809,0.00008503817,0.002100813],"genre_scores_gemma":[0.9869601,0.002908375,0.001613471,0.001432905,0.0004863057,0.002898117,0.0008847574,0.00002727099,0.002788617],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005640978,"threshold_uncertainty_score":0.01887095,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07239729487824467,"score_gpt":0.3808896184690667,"score_spread":0.308492323590822,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}